Literature DB >> 23285435

Prevalence of Serum Antibodies to TORCH Infection in and Around Varanasi, Northern India.

M R Sen1, B N Shukla, Banerjee Tuhina.   

Abstract

BACKGROUND: The acute infections which are caused by Toxoplasma gondii, Rubella virus, Cytomegalovirus (CMV) and the Herpes Simplex Virus (HSV-2) during pregnancy are often associated with adverse foetal outcomes and reproductive failures. In the Indian context, the exact seroprevalence of these infections is not known due to unavailability of baseline data. AIMS: The present study was undertaken to determine the serological evidence of the acute TORCH infections in women who were in the first trimesters of their pregnancies in and around Varanasi, north India. SETTINGS AND
DESIGN: This study was carried out in the Sir Sunderlal Hospital, Varanasi and in the Department of Microbiology, Institute of Medical Sciences, BHU, Varanasi, UP, India. The study population involved pregnant women with bad obstetric histories, who were in the first trimester of their pregnancy. METHODS AND MATERIALS: Sera were collected from the women with Bon and they were tested for the presence of specific IgM antibodies against the TORCH infections by ELISA. STATISTICAL ANALYSIS: A 95% confidence interval was calculated for the positive cases in each of the TORCH components.
RESULTS: The specific IgM antibodies were found to be positive in 74(19.4%) cases for toxoplasmosis, in 126 (30.4%) cases for the Rubella virus, in 130 (34.7%) cases for CMV and in 151 samples (33.5%) for the HSV-2 infections.
CONCLUSIONS: The study showed a high prevalence of the infections which were caused by the TORCH complex amongst pregnant women with bad obstetric histories. Therefore, all the antenatal cases should be routinely screened for the TORCH infections, for carrying out early interventions to prevent foetal loss.

Entities:  

Keywords:  Antibodies; Pregnant; Serological; Specific IgM; TORCH

Year:  2012        PMID: 23285435      PMCID: PMC3527775          DOI: 10.7860/JCDR/2012/4550.2538

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  Prevalence of serum antibodies to TORCH among women before pregnancy or in the early period of pregnancy in Beijing.

Authors:  Zhiyan Li; Cuiling Yan; Ping Liu; Rong Yan; Zhenru Feng
Journal:  Clin Chim Acta       Date:  2009-03-18       Impact factor: 3.786

2.  Toxoplasmosis in South India--a serological study.

Authors:  V N Bhatia; K Meenakshi; S C Agarwal
Journal:  Indian J Med Res       Date:  1974-12       Impact factor: 2.375

3.  Rubella and pregnancy. ACOG Technical Bulletin Number 171--August 1992.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  1993-07       Impact factor: 3.561

4.  Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

Authors:  S B Boppana; L B Rivera; K B Fowler; M Mach; W J Britt
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

5.  Consequences of confirmed maternal rubella at successive stages of pregnancy.

Authors:  E Miller; J E Cradock-Watson; T M Pollock
Journal:  Lancet       Date:  1982-10-09       Impact factor: 79.321

6.  Immunity to rubella among women of child-bearing age.

Authors:  A M Lever; M G Ross; C Baboonian; P D Griffiths
Journal:  Br J Obstet Gynaecol       Date:  1987-03

7.  The seroepidemiology of Rubella in Amritsar (Punjab).

Authors:  N Singla; N Jindal; A Aggarwal
Journal:  Indian J Med Microbiol       Date:  2004 Jan-Mar       Impact factor: 0.985

8.  Seroprevalence of torch infection in bad obstetric history.

Authors:  D Turbadkar; M Mathur; M Rele
Journal:  Indian J Med Microbiol       Date:  2003 Apr-Jun       Impact factor: 0.985

9.  Mother-to-child transmission and diagnosis of Toxoplasma gondii infection during pregnancy.

Authors:  S Singh
Journal:  Indian J Med Microbiol       Date:  2003 Apr-Jun       Impact factor: 0.985

  9 in total
  7 in total

1.  Evaluation of the HerpeSelect Express rapid test in the detection of herpes simplex virus type 2 antibodies in patients with genital ulcer disease.

Authors:  Hani Al-Shobaili; Khaled M Hassanein; Marwa Salah Mostafa; Ali Saleh Al Duways
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

2.  Seroprevalence of TORCH infections in antenatal and HIV positive patient populations.

Authors:  Lavan Singh; Siddhartha Mishra; S Prasanna; M P Cariappa
Journal:  Med J Armed Forces India       Date:  2015-02-16

Review 3.  Human infectious diseases and risk of preeclampsia: an updated review of the literature.

Authors:  Malihe Nourollahpour Shiadeh; Zahra Behboodi Moghadam; Ishag Adam; Vafa Saber; Maryam Bagheri; Ali Rostami
Journal:  Infection       Date:  2017-06-02       Impact factor: 3.553

4.  Detection of TORCH pathogens in children with congenital cataracts.

Authors:  Bin Lu; Yabo Yang
Journal:  Exp Ther Med       Date:  2016-05-17       Impact factor: 2.447

5.  Seroprevalence and Influence of Torch Infections in High Risk Pregnant Women: A Large Study from South India.

Authors:  K Rebekah Prasoona; B Srinadh; T Sunitha; M Sujatha; M L N Deepika; B Vijaya Lakshmi; Aruna Ramaiah; A Jyothy
Journal:  J Obstet Gynaecol India       Date:  2014-10-29

6.  Seroprevalence of Toxoplasma, Rubella, and Cytomegalovirus among pregnant women in Van.

Authors:  Mehmet Parlak; Numan Çim; Begüm Nalça Erdin; Ayşe Güven; Yasemin Bayram; Recep Yıldızhan
Journal:  Turk J Obstet Gynecol       Date:  2015-06-15

7.  The Screening of Rubella Virus, Cytomegalovirus, Hepatitis B Virus, and Toxoplasma gondii Antibodies in Prepregnancy and Reproductive-Age Women in Tabriz, Iran.

Authors:  Edris Nabizadeh; Anahita Ghotaslou; Behnaz Salahi; Reza Ghotaslou
Journal:  Infect Dis Obstet Gynecol       Date:  2022-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.